While maintaining blood stocks is difficult and pharmaceutical companies want to collect in all European countries, will blood donation be remunerated in France soon?
On July 14, the European Commission presented a proposal for a regulation, the fruit of three years of work, aimed at better regulating blood transfusions and transplants. This regulation comes within the framework of the revision of the European texts governing donations of human blood, tissues and cells.
This draft regulation aims to adapt two directives, drawn up some twenty years ago. This aims above all to provide greater security for both patients and donors, but also to improve the quality and inter-country circulation of donations.
For this, the text proposes the establishment of a platform common to all European countries to accumulate data, whether on the number of donors, the type of transplant or even to monitor the evolution of side effects in patients and donors. In the event of a sudden drop in donations, the entities concerned will be required to set up emergency plans.
What about paid blood donation?
The text does not give a directive on this subject, whereas remunerated plasma donation is practiced in Germany and Hungary and certain manufacturers wish to develop their businesses in other European countries.
During the debates in the European Parliament on this text, discussions on remunerated blood donation will be opened and there will be great pressure on elected representatives, between countries which refuse this opening (such as France), and pharmaceutical companies which want to demonstrate that ‘with this opening, Europe will become self-sufficient in blood-derived medicines.